Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19

Pharmacol Res Perspect. 2023 Apr;11(2):e01083. doi: 10.1002/prp2.1083.
No abstract available

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • COVID-19*
  • Humans
  • Hypertension* / drug therapy
  • Losartan / pharmacology
  • Losartan / therapeutic use
  • Telmisartan / therapeutic use

Substances

  • Losartan
  • Telmisartan
  • Antihypertensive Agents